174 related articles for article (PubMed ID: 24441504)
1. New developments in the treatment of squamous cell lung cancer.
Filipits M
Curr Opin Oncol; 2014 Mar; 26(2):152-8. PubMed ID: 24441504
[TBL] [Abstract][Full Text] [Related]
2. Personalized therapy on the horizon for squamous cell carcinoma of the lung.
Kim HS; Mitsudomi T; Soo RA; Cho BC
Lung Cancer; 2013 Jun; 80(3):249-55. PubMed ID: 23489560
[TBL] [Abstract][Full Text] [Related]
3. Genetic alterations defining NSCLC subtypes and their therapeutic implications.
Pikor LA; Ramnarine VR; Lam S; Lam WL
Lung Cancer; 2013 Nov; 82(2):179-89. PubMed ID: 24011633
[TBL] [Abstract][Full Text] [Related]
4. Clinical applications of The Cancer Genome Atlas project (TCGA) for squamous cell lung carcinoma.
Devarakonda S; Morgensztern D; Govindan R
Oncology (Williston Park); 2013 Sep; 27(9):899-906. PubMed ID: 24282988
[TBL] [Abstract][Full Text] [Related]
5. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas.
Campbell JD; Alexandrov A; Kim J; Wala J; Berger AH; Pedamallu CS; Shukla SA; Guo G; Brooks AN; Murray BA; Imielinski M; Hu X; Ling S; Akbani R; Rosenberg M; Cibulskis C; Ramachandran A; Collisson EA; Kwiatkowski DJ; Lawrence MS; Weinstein JN; Verhaak RG; Wu CJ; Hammerman PS; Cherniack AD; Getz G; ; Artyomov MN; Schreiber R; Govindan R; Meyerson M
Nat Genet; 2016 Jun; 48(6):607-16. PubMed ID: 27158780
[TBL] [Abstract][Full Text] [Related]
6. Clinical next-generation sequencing successfully applied to fine-needle aspirations of pulmonary and pancreatic neoplasms.
Young G; Wang K; He J; Otto G; Hawryluk M; Zwirco Z; Brennan T; Nahas M; Donahue A; Yelensky R; Lipson D; Sheehan CE; Boguniewicz AB; Stephens PJ; Miller VA; Ross JS
Cancer Cytopathol; 2013 Dec; 121(12):688-94. PubMed ID: 23893923
[TBL] [Abstract][Full Text] [Related]
7. Lung cancer adrenal gland metastasis: Optimal fine-needle aspirate and touch preparation smear cellularity characteristics for successful theranostic next-generation sequencing.
Gleeson FC; Kipp BR; Levy MJ; Voss JS; Campion MB; Minot DM; Tu ZJ; Klee EW; Lazaridis KN; Kerr SE
Cancer Cytopathol; 2014 Nov; 122(11):822-32. PubMed ID: 25045116
[TBL] [Abstract][Full Text] [Related]
8. miR-205 Expression levels in nonsmall cell lung cancer do not always distinguish adenocarcinomas from squamous cell carcinomas.
Del Vescovo V; Cantaloni C; Cucino A; Girlando S; Silvestri M; Bragantini E; Fasanella S; Cuorvo LV; Palma PD; Rossi G; Papotti M; Pelosi G; Graziano P; Cavazza A; Denti MA; Barbareschi M
Am J Surg Pathol; 2011 Feb; 35(2):268-75. PubMed ID: 21263248
[TBL] [Abstract][Full Text] [Related]
9. Genomic landscape of squamous cell carcinoma of the lung.
Morgensztern D; Devarakonda S; Govindan R
Am Soc Clin Oncol Educ Book; 2013; ():348-53. PubMed ID: 23714544
[TBL] [Abstract][Full Text] [Related]
10. Metastatic non-small cell lung cancer management: novel targets and recent clinical advances.
Riess JW; Wakelee HA
Clin Adv Hematol Oncol; 2012 Apr; 10(4):226-34. PubMed ID: 22706483
[TBL] [Abstract][Full Text] [Related]
11. Targeting the phosphatidylinositol 3-kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR) pathway: an emerging treatment strategy for squamous cell lung carcinoma.
Beck JT; Ismail A; Tolomeo C
Cancer Treat Rev; 2014 Sep; 40(8):980-9. PubMed ID: 25037117
[TBL] [Abstract][Full Text] [Related]
12. Identification of genes involved in squamous cell carcinoma of the lung using synchronized data from DNA copy number and transcript expression profiling analysis.
Lo KC; Stein LC; Panzarella JA; Cowell JK; Hawthorn L
Lung Cancer; 2008 Mar; 59(3):315-31. PubMed ID: 18029052
[TBL] [Abstract][Full Text] [Related]
13. Advances in treatment of lung cancer with targeted therapy.
Cagle PT; Chirieac LR
Arch Pathol Lab Med; 2012 May; 136(5):504-9. PubMed ID: 22540298
[TBL] [Abstract][Full Text] [Related]
14. Role of FGF receptors as an emerging therapeutic target in lung squamous cell carcinoma.
Lim SM; Kim HR; Shim HS; Soo RA; Cho BC
Future Oncol; 2013 Mar; 9(3):377-86. PubMed ID: 23469973
[TBL] [Abstract][Full Text] [Related]
15. [Challenge of gene-based personalized lung cancer medicine].
Seki Y; Kohno T
Nihon Rinsho; 2015 Aug; 73(8):1373-7. PubMed ID: 26281692
[TBL] [Abstract][Full Text] [Related]
16. Genomic copy number alterations associated with the early brain metastasis of non-small cell lung cancer.
Lee HW; Seol HJ; Choi YL; Ju HJ; Joo KM; Ko YH; Lee JI; Nam DH
Int J Oncol; 2012 Dec; 41(6):2013-20. PubMed ID: 23076643
[TBL] [Abstract][Full Text] [Related]
17. Characterization of cell-type specific profiles in tissues and isolated cells from squamous cell carcinomas of the lung.
Hawthorn L; Stein L; Panzarella J; Loewen GM; Baumann H
Lung Cancer; 2006 Aug; 53(2):129-42. PubMed ID: 16757060
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive genomic characterization of squamous cell lung cancers.
Cancer Genome Atlas Research Network
Nature; 2012 Sep; 489(7417):519-25. PubMed ID: 22960745
[TBL] [Abstract][Full Text] [Related]
19. Folate receptor in adenocarcinoma and squamous cell carcinoma of the lung: potential target for folate-linked therapeutic agents.
Cagle PT; Zhai QJ; Murphy L; Low PS
Arch Pathol Lab Med; 2013 Feb; 137(2):241-4. PubMed ID: 22984810
[TBL] [Abstract][Full Text] [Related]
20. [Progress on the Study of Targeting FGFR in Squamous Non-small Cell Lung Cancer].
Dong M; Li T; Chen J
Zhongguo Fei Ai Za Zhi; 2018 Feb; 21(2):116-120. PubMed ID: 29526179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
